Skip to main content

Table 3 Clinical characteristics of amyloidosis (N = 6) patients with VTD

From: Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis

Characteristics  
Male/Female 4/2
History of VTD  
Personal  
   Yes 1
   No 5
Family  
   No 6
Serum M-Protein 1  
   None 3
   Yes 2
   Unknown 1
24-hour Urine Protein 1  
   <0.15 gr 3
   >0.15 gr 2
   Unknown 1
BMPC 2  
   ≤ 5% 3
   > 5% 1
   Unknown 2
B 2 Microglobulin 1  
   < 1.9 mg/L 1
   > 1.9 mg/L 4
   Unknown 1
Serum albumin 1  
   < 3.5 g/L 3
   3.5 – 5.0 g/L 3
Immunoglobulin type  
   None 4
   IgG 1
   IgM 1
   None 4
   κ 2
WBC count  
   4 – 11 × 106/L 6
Platelet count  
   150 – 400 × 106/L 6
  1. 1CCF Laboratory reference range, normal values:
  2. Serum M-protein: 0 g/dl
  3. Urine Protein: 0–0.15 g/24°
  4. β2 Macroglobulin: 0.3–1.9 g/dl
  5. Serum Albumin: 3.5–5.0 g/L
  6. 2 Bone Marrow Plasma Cells